Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004854 · ClinicalTrials.gov registry record · Phase 1
The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure
A Phase 1 study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004854: Completed Phase 1 study, sponsored by National Center for Research Resources (NCRR).
NCT00004854 is a Phase 1 study that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004854, a Phase 1 study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
We would like to see if using Carvedilol in adjunct with Ace inhibitors will increase ejection fraction of the heart under echo. All interpretation of data will be sent to Boston Children's Hospital to be reviewed, which is the primary research center in this study. There are 5 hospitals participating in this study. The population targeted are children with moderate heart failure and must be on Ace inhibitors at the time of enrollment. Our outcome after placing them on Carvedilol is to change their ejection fraction on echo. The patients will be seen every 1-2 weeks, while we will titrate their medication to a maintenance dose. Secondary outcome is to increase quality of life, exercise tolerance and decrease their symptom scores as noted on their questionnaires.
Interventions
- DRUG Carvedilol
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00004854 record still lists
NCT00004854 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Carvedilol is the first listed.
NCT00004854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004854 about?
NCT00004854 is a clinical study titled "The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure". We would like to see if using Carvedilol in adjunct with Ace inhibitors will increase ejection fraction of the heart under echo. All interpretation of data will be sent to Boston Children's Hospital to be reviewed, which is the primary research center in this study. There are 5 hospitals participati...
What is the current status of trial NCT00004854?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00004854?
The interventions under investigation include: Carvedilol (DRUG).
Who is sponsoring clinical trial NCT00004854?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.